NasdaqGS:LEGNBiotechs
What Legend Biotech (LEGN)'s CFO Appointment Means for Shareholders
On August 18, 2025, Legend Biotech announced the appointment of Carlos Santos as Chief Financial Officer and principal accounting officer, succeeding interim CFO Jessie Yeung.
The addition of Mr. Santos, who brings significant financial leadership experience from AstraZeneca, Novartis, and Intel, signals a meaningful shift in Legend Biotech's executive management capability.
We'll discuss how the appointment of a new CFO with broad global expertise may shape Legend Biotech’s investment...